Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: comparison with F-18-FDG PET.
暂无分享,去创建一个
Georgios Karanikas | Marius E Mayerhoefer | G. Karanikas | Michael Weber | M. Mayerhoefer | T. Knogler | K. El-Rabadi | Michael Weber | Thomas Knogler | Karem El-Rabadi
[1] J. Rademaker. Hodgkin's and non-Hodgkin's lymphomas. , 2007, Radiologic clinics of North America.
[2] G. Salles,et al. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] M Tubiana,et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] Sung Ho Hwang,et al. Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy , 2013, European Radiology.
[5] Andrzej Materka,et al. Texture analysis for magnetic resonance imaging , 2006 .
[6] Vicky Goh,et al. Are Pretreatment 18F-FDG PET Tumor Textural Features in Non–Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy? , 2013, The Journal of Nuclear Medicine.
[7] Ora Israel,et al. 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients , 2010, Journal of Nuclear Medicine.
[8] Andrzej Materka,et al. Effects of MRI acquisition parameter variations and protocol heterogeneity on the results of texture analysis and pattern discrimination: an application-oriented study. , 2009, Medical physics.
[9] V. Goh,et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. , 2011, Radiology.
[10] Thomas C Kwee,et al. Imaging in staging of malignant lymphoma: a systematic review. , 2008, Blood.
[11] M. Kurrer,et al. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed? , 2007, Radiology.
[12] E. Kerviler,et al. From multislice CT to whole-body biomarker imaging in lymphoma patients , 2011, European Radiology.
[13] Siegfried Trattnig,et al. Texture‐based classification of focal liver lesions on MRI at 3.0 Tesla: A feasibility study in cysts and hemangiomas , 2010, Journal of magnetic resonance imaging : JMRI.
[14] S. Mirzaei,et al. Prognostic significance of the standardized uptake value of pre-therapeutic 18F-FDG PET in patients with malignant lymphoma , 2011, Medical oncology.
[15] Jianhua Yao,et al. CT grading of lung disease in lymphangioleiomyomatosis. , 2012, AJR. American journal of roentgenology.
[16] C. Chatwin,et al. Dynamic Contrast-Enhanced Texture Analysis of the Liver: Initial Assessment in Colorectal Cancer , 2011, Investigative radiology.
[17] Mary M. Galloway,et al. Texture analysis using gray level run lengths , 1974 .
[18] J. Tian,et al. Characterization of adrenal metastatic cancer using FDG PET/CT. , 2012, Neoplasma (Bratislava).
[19] S. Hain,et al. 18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CT , 2000, Leukemia & lymphoma.
[20] L. Brepoels,et al. PET and PET/CT for response evaluation in lymphoma: Current practice and developments , 2007, Leukemia & lymphoma.
[21] Prasun Dastidar,et al. Texture analysis on MRI images of non-Hodgkin lymphoma , 2008, Comput. Biol. Medicine.
[22] P. Dupont,et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods? , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Higuchi,et al. Prognostic impact of FDG-PET in surgically treated pathological stage I lung adenocarcinoma. , 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.
[24] Jeong Hyun Lee,et al. Prognostic Value of Tumor 18F-FDG Uptake in Patients with Untreated Extranodal Natural Killer/T-Cell Lymphomas of the Head and Neck , 2008, Journal of Nuclear Medicine.
[25] G. Jerusalem,et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. , 1999, Blood.
[26] J. Kuruvilla,et al. Treatment of newly diagnosed advanced stage Hodgkin lymphoma. , 2012, Blood reviews.
[27] G. Karanikas,et al. Assessment of pulmonary melanoma metastases with 18F-FDG PET/CT: which PET-negative patients require additional tests for definitive staging? , 2012, European Radiology.
[28] M K Markey,et al. Application of the mutual information criterion for feature selection in computer-aided diagnosis. , 2001, Medical physics.
[29] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[30] R. Hicks,et al. Overview of early response assessment in lymphoma with FDG-PET , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.
[31] R. Houot,et al. Diagnostic and prognostic impact of 18F-FDG PET/CT in follicular lymphoma , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[32] S. Iwano,et al. What causes false-negative PET findings for solid-type lung cancer? , 2013, Lung cancer.
[33] R.M. Haralick,et al. Statistical and structural approaches to texture , 1979, Proceedings of the IEEE.
[34] Peter Gibbs,et al. Texture analysis in assessment and prediction of chemotherapy response in breast cancer , 2013, Journal of magnetic resonance imaging : JMRI.
[35] K. Miles,et al. Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.